Food News and Research

RSS

Improved productivity and lowered absenteeism are top priorities for business leaders

Improving productivity by keeping employees healthy and working is emerging as the top business objective for employer-sponsored wellness programs around the world. The two exceptions are the United States, where reducing health care cost increases overwhelmingly continues to be the top goal, and Asia, where the most important objective is improving workforce morale.

17 Nov 2009

Genentech submits sBLAs to the FDA for Avastin

Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.

17 Nov 2009

FDA provides feedback on the pending NDA for EXALGO tablets

CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate EXALGOTM (hydromorphone HCl extended release) tablets, seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time, with staff from the United States Food and Drug Administration (FDA).

17 Nov 2009

Roche receives EUA from FDA for its RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 virus

Roche`s RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 influenza virus has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). The Roche kit detects RNA from the 2009 H1N1 influenza A virus and allows rapid and accurate identification of patients infected with this virus.

17 Nov 2009

Titanium dioxide nanoparticles causes systemic genetic damage in mice, say researchers

Titanium dioxide (TiO2) nanoparticles, found in everything from cosmetics to sunscreen to paint to vitamins, caused systemic genetic damage in mice, according to a comprehensive study conducted by researchers at UCLA's Jonsson Comprehensive Cancer Center.

17 Nov 2009

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

NeurogesX, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza(TM) (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia (PHN), the nerve pain which can follow shingles.

17 Nov 2009

FDA approves Par Pharmaceutical's new painkiller drug

Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for the 100mg and 200mg strengths of tramadol ER.

17 Nov 2009

HealthBarn USA showcases its integrated curricula among educators and farmers at FBEA conference

HealthBarn USA®, www.healthbarnusa.com, a proven leader in healthy-lifestyle education for children and families, presented at the national Farm-Based Education Association (FBEA), www.farmbasededucation.org, conference in Tarrytown, NY held November 12-14, 2009.

17 Nov 2009

ARCA biopharma provides financial and Gencaro NDA update

ARCA biopharma, Inc. today announced its planned next steps in response to the May 29, 2009 Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for ARCA’s New Drug Application (NDA) seeking approval for GencaroTM (bucindolol hydrochloride) for the treatment of patients with chronic heart failure. Following receipt of the CRL, the Company and the FDA have held a series of meetings to discuss how best to address the requirements identified in the CRL.

17 Nov 2009

FDA approves CSL's seasonal and H1N1 flu vaccines for children

The U.S. Food and Drug Administration has approved the use of the CSL Limited's seasonal and 2009 H1N1 influenza vaccines to include children ages 6 months and older. These vaccine were previously approved for use in adults, ages 18 years and older

17 Nov 2009

Health Mason software to streamline health care claim payment process

With health care reform taking the national spotlight, the sole point of agreement by all parties is that some form of change is necessary. Many health care industry experts believe that now is the worst time for government-mandated change because innovation has already begun to occur organically from within the industry. One Franklin Tennessee-based software company is defining that innovation and garnering attention in the industry.

17 Nov 2009

Food allergies among children is increasing: Study

A newly published article provides further evidence that the prevalence of food allergies among children is increasing. The article, "Food Allergy Among Children in the United States" appears in the December issue of Pediatrics, a US medical journal.

17 Nov 2009

HealthTrans Access sponsors 50 disadvantaged families to free healthcare support

HealthTrans Access, a comprehensive discount healthcare provider, has arranged for 50 disadvantaged families from the Greater Denver and Boulder areas to receive one year of membership in the HealthTrans Access discount healthcare program at no cost. In partnership with Denver Human Services and several of their community organizations, HealthTrans Access is providing families with its Premium discount program, which provides deep discounts for healthcare services for the entire family.

17 Nov 2009

NIH awards $3 million grant to ASU professors for research on rapid DNA sequencing technology

Arizona State University has been awarded nearly $3 million in federal stimulus funds from the National Institutes of Health. ASU professors Stuart Lindsay and Paul Westerhoff will lead a pair of two-year, innovative projects designed to tackle challenges in the fields of rapid DNA sequencing and the potential health risks of nanotechnology.

17 Nov 2009

Additional vaccine for 2009 H1N1 flu approved by FDA

The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC.

16 Nov 2009

Opinions: Health system funding; malnutrition assistance; social dimension of HIV

"For too long, global health funding has gone to diseases like AIDS with the most vocal lobby groups and not to the diseases with the greatest need," Philip Stevens, a senior fellow at International Policy Network, writes in a Business Daily opinion piece.

16 Nov 2009

World Food Summit focuses on aiding agriculture in developing countries to fight hunger

Delegates at the World Summit on Food Security, which kicked off Monday, "rallied around a new strategy to fight global hunger and help poor countries feed themselves," the Associated Press reports.

16 Nov 2009

Eisai's LUSEDRA Injection now available for MAC sedation

Eisai Inc. today announced that LUSEDRA(TM) (fospropofol disodium) Injection is now available for use by persons trained in the administration of general anesthesia. LUSEDRA, an aqueous solution, is an intravenous sedative-hypnotic agent indicated for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.

16 Nov 2009

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Sciele Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd. and Addrenex Pharmaceuticals, Inc., a privately-held U.S. pharmaceutical company specializing in developing drugs that regulate the adrenergic system, today announced that Sciele has agreed to acquire Addrenex.

16 Nov 2009

China Medicine reports total revenues of $19.2M for the third quarter of 2009

China Medicine Corporation, a developer and a leading distributor of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, and medical devices and medical formulations, today announced its third quarter 2009 results.

16 Nov 2009

Food News and Research

Improved productivity and lowered absenteeism are top priorities for business leaders

Genentech submits sBLAs to the FDA for Avastin

FDA provides feedback on the pending NDA for EXALGO tablets

Roche receives EUA from FDA for its RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 virus

Titanium dioxide nanoparticles causes systemic genetic damage in mice, say researchers

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

FDA approves Par Pharmaceutical's new painkiller drug

HealthBarn USA showcases its integrated curricula among educators and farmers at FBEA conference

ARCA biopharma provides financial and Gencaro NDA update

FDA approves CSL's seasonal and H1N1 flu vaccines for children

Health Mason software to streamline health care claim payment process

Food allergies among children is increasing: Study

HealthTrans Access sponsors 50 disadvantaged families to free healthcare support

NIH awards $3 million grant to ASU professors for research on rapid DNA sequencing technology

Additional vaccine for 2009 H1N1 flu approved by FDA

Opinions: Health system funding; malnutrition assistance; social dimension of HIV

World Food Summit focuses on aiding agriculture in developing countries to fight hunger

Eisai's LUSEDRA Injection now available for MAC sedation

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

China Medicine reports total revenues of $19.2M for the third quarter of 2009

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News